Rufloxacin
![]() | |
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | oral |
| ATC code | J01MA10 (WHO) |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| Synonyms | 7-Fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid |
| CAS Number |
101363-10-4 |
| PubChem (CID) | 58258 |
| ChemSpider |
52489 |
| UNII |
Y521XM2900 |
| ChEMBL |
CHEMBL295619 |
| Chemical and physical data | |
| Formula | C17H18FN3O3S |
| Molar mass | 363.406 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Rufloxacin is a quinolone antibiotic.[1] It is sold under the brand names, Ruflox, Monos, Qari, Tebraxin, Uroflox, Uroclar.
See also
References
- ↑ Rafalsky, V.; Andreeva, I.; Rjabkova, E. (2006). "Quinolones for uncomplicated acute cystitis in women.". Cochrane Database Syst Rev. 3: CD003597. doi:10.1002/14651858.CD003597.pub2. PMID 16856014.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

